Roche boosts Olema after additional late-stage trial data...

2025-12-10 09:07:19 ET More on Roche, Olema Pharmaceuticals Roche May Be Riding A Bit Too High, But Remains Interesting Roche - Despite Some Study Setbacks, Pipeline Gives Me Increasing Confidence Olema Pharmaceuticals: Shares Double On Roche's MBC Data - I Preach Caution Genentech releases Lunsumio data in earlier treatment lines for lymphomas FDA top drugs official Pazdur retiring shortly after starting Read the full article on Seeking Alpha For further details see: Roche boosts Olema after additional late-stage trial data for breast cancer drug